- Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study. Alberts, D.S., Blessing, J.A., Landrum, L.M., Warshal, D.P., Martin, L.P., Rose, S.L., Bonebrake, A.J., Ramondetta, L.M. Gynecol. Oncol. (2012)